Triumvira Immunologics

Developer of T-cell therapies for treating cancers

placeAustin, Texas, United States calendar_todayFounded 2015 groups85 employees language triumvira.com

Registered entities

Investor mix

13 investors on record; lead investors include Leaps by Bayer, Northpond Ventures.

Investor typeCountShare
Venture capital862%
Private equity18%
Bank & private debt18%
Other / undisclosed323%
Coming soon